Incentivizing HIV Testing Critical To Ensuring People Get Tested, Reaching U.N. 90-90-90 Target

The Lancet: Achieving the 90-90-90 target: incentives for HIV testing
Mark A. Wainberg, head of AIDS research at the Lady Davis Institute for Medical Research (LDI), director of the McGill University AIDS Centre, and professor at McGill University, and colleagues

“…HIV testing remains underused, and late diagnoses of HIV infection continue to cause problems. Far too many HIV-infected people are unaware of their status. … To achieve HIV elimination, identifying all individuals potentially living with undiagnosed HIV infection is critical. Systematic uptake of existing evidence-based testing strategies is a necessary component of public health programs. Additionally, we recommend consideration of HIV testing that is incentivized through associated cash transfer, or a culturally and socially appropriate non-financial incentive. The relatively small cost associated with providing financial incentives to people to be tested would probably be vastly eclipsed by the averted costs associated with the prevention of ongoing transmission. Enhanced diagnosis is the first step to ensuring that the U.N. 90-90-90 target will be realized” (November 2016).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.